Egalet Corporation (Nasdaq:EGLT), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Robert Radie, President and CEO, will ring the Closing Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Thursday, March 30, 2017 – 3:45 p.m. to 4:00 p.m. ET